Digital substance use management platform Pelago, formerly Quit Genius, announced it secured $58 million in Series C funding, bringing its total raise to $151 million.
Existing investor Atomico led the round, with participation from other continuing investors, including Octopus Ventures, Y Combinator and Kinnevik AB. New investors GreyMatter Capital and Eight Roads also participated.
Laura...
Evernorth, the health services arm of insurer Cigna, announced it has added five new programs to its digital health formulary, including offerings from Big Health and Quit Genius.
The new additions to the formulary are Big Health's Sleepio digital therapeutic for insomnia and its Daylight tool for anxiety, Quit Genius' alcohol use disorder and opioid use disorder programs, and HealthBeacon's...
Addiction recovery platform Quit Genius is diving into the payer space thanks to a new partnership with B2B insurance company Evry Health. As part of the deal, Evry Health's Dallas-based members will have access to Quit Genius' digital services, which include treatment for tobacco, alcohol and opioid addiction.
This move is part of Quit Genius' larger strategy to expand into the payer market.
"...
Quit Genius, a digital treatment platform for addiction, closed a $64 million Series B funding round. The round was co-led by Kinnevik and Atomico, with additional participation from Octopus Ventures, Triple Point Ventures and Startup Health.
This, in addition to the company's Series A round from last year, brings its total amount raised to $77.5 million.
WHAT THEY DO
Quit Genius offers treatment...
The smoking-cessation digital-therapeutic app Quit Genius was found to be an effective treatment for people trying to stop smoking, especially when they are compared to individuals seeking out their own regimen, according to new research from JMIR Mental Health.
The results from this study were only indicative for the short term, but researchers noted that a subsequent paper would be published...
More digital health tools join the PBM party. Evernorth, a newly-established Cigna subsidiary that now acts as the parent of Express Scripts, announced today several new additions to the pharmacy benefit manager's Digital Health Formulary. Joining the lineup in 2021 will be:
Wildflower Health's app-based women's health offering.
Quit Genius's digital program for smoking and vaping cessation....
Quit Genius, a digital addiction-recovery program, has extended its platform to support alcohol and opioid addictions.
The program is designed for enterprise and health plan customers in the U.S. to help their employees recover from addiction.
Fees are paid for by the user’s employer or health plan. Employers are charged an annual fee for each participant that actually enrolls in the program.
The...
Yesterday morning addiction focused digital therapeutic Quit Genius scored $11 million in Series A funding. Octopus Ventures led the round with participation from Y Combinator, Startup Health and Triple Point Ventures.
This brings the company's total funding pot to $13.5 million.
WHAT THEY DO
The company is geared at treating individuals with tobacco-, opioid- and alcohol-use disorder through...
Telemedicine reduces gender-based barriers to health. A study showing that telemedicine improves access to care for women and girls in Nepal has won an Atlas Award. The study, originally published in May 2017, shows that telemedicine, delivered via video conferencing or mobile apps, reduces gender-based barriers to accessing care by eliminating the need for travel and reducing the cost to the...
